Lymphoma, Non-Hodgkin: all 2,043 studies
Page 18 of 21. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaTerminatedNCT00367497Phase 2
- Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00364676Phase 1
- A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)TerminatedNCT00363636Phase 3
- Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
- Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's LymphomaCompletedNCT00354926Phase 1
- Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.TerminatedNCT00354822Phase 2
- PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaTerminatedNCT00354185Phase 1
- PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC TransplantationCompletedNCT00352703Phase 4
- Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCTCompletedNCT00350181Phase 2
- PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasCompletedNCT00348985Phase 1
- Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's LymphomaCompletedNCT00347971Phase 1
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Interdisciplinary Case-Control Study of Non-Hodgkin's LymphomaCompletedNCT00341952
- The Second Multicenter Hemophilia Cohort StudyCompletedNCT00341705
- Genome Expression in Lymphoma, Leukemia and Multiple MyelomaCompletedNCT00339963
- Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's LymphomaCompletedNCT00336843Phase 2
- A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Status unknownNCT00333008Phase 2
- Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeCompletedNCT00327132Not applicable
- Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid TreatmentStatus unknownNCT00324467Phase 2
- Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00323934Phase 1
- A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's LymphomaCompletedNCT00322985Phase 2
- A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic RegimenWithdrawnNCT00319332Phase 3
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesCompletedNCT00317785Phase 2
- FCM Versus R-FCM Followed by R-Maintenance or Observation OnlyStatus unknownNCT00317096Phase 3
- Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCompletedNCT00311129Phase 2
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWithdrawnNCT00310128Phase 2
- Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphomaCompletedNCT00306111Phase 2
- Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin LymphomaCompletedNCT00302757Phase 1/2
- Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaTerminatedNCT00301795Phase 2
- A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).CompletedNCT00301288
- Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.CompletedNCT00298779Phase 1
- 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00293345Phase 1
- Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's LymphomaCompletedNCT00285428Phase 1/2
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)CompletedNCT00285259Phase 2
- Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell LymphomaCompletedNCT00283985Phase 2
- Sorafenib in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00278382Phase 2
- Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaCompletedNCT00275080Phase 1
- External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's LymphomaCompletedNCT00271050Phase 1
- Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaTerminatedNCT00265928Phase 2
- A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus CarriersCompletedNCT00262210Phase 2
- A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing ChemotherapyCompletedNCT00261677Phase 3
- Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CTCompletedNCT00256490Not applicable
- Study of TPI 287 Administered Every 21 Days in Patients With Advanced MalignanciesCompletedNCT00256191Phase 1
- Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular LymphomaCompletedNCT00251394Phase 2
- Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's LymphomaTerminatedNCT00250861Phase 2
- Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00244946Phase 1
- Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 TositumomabCompletedNCT00240591
- Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 TositumomabCompletedNCT00240578
- Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00240565Phase 2
- Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow TransplantCompletedNCT00238368Phase 2
- Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/LymphomaCompletedNCT00232440Phase 1/2
- Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT00220285Phase 2
- Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
- A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaCompletedNCT00211276Phase 2
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2
- Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00204659Phase 2
- A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00201669Phase 2
- A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface AntigenCompletedNCT00201318Phase 2
- Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade LymphomaCompletedNCT00199043Phase 3
- Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise TrainingCompletedNCT00196885Phase 2
- Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic LymphomaStatus unknownNCT00195871Phase 2
- Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's LymphomaCompletedNCT00193440Phase 2
- High Dose CHOP in LymphomaCompletedNCT00192764Phase 2
- Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's LymphomaCompletedNCT00188929Phase 2
- Ultrasound Biomicroscopy - ApoptosisCompletedNCT00188370Phase 2
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Treatment for Patients With Stage III or IV Non-Hodgkin LymphomaCompletedNCT00187122Not applicable
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
- Haploidentical Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00186823Phase 3
- 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHLCompletedNCT00186589Phase 1
- High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's LymphomaCompletedNCT00186394Phase 2
- Enrichment & Purging of Stem Cells in Non-Hodgkin's LymphomaCompletedNCT00186355Not applicable
- Allo BMT in Advanced Leukemia or High Grade LymphomaCompletedNCT00186290Not applicable
- Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHLCompletedNCT00185445Phase 2
- Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line ChemotherapyCompletedNCT00185393Phase 3
- Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00184080Phase 2
- Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's LymphomasTerminatedNCT00183976Phase 2
- Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to ChemotherapyTerminatedNCT00183950Phase 1/2
- Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular LymphomaCompletedNCT00177554Phase 2
- Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's LymphomaCompletedNCT00169208Phase 2
- Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's LymphomaCompletedNCT00168727Phase 4
- Prevention of CHOP-induced Chronic CardiotoxicityCompletedNCT00162955Phase 4
- Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell LymphomaCompletedNCT00161590Phase 1
- Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: RadiationStatus unknownNCT00154440Phase 3
- Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00147953Phase 2
- A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced CancerTerminatedNCT00147485Phase 1
- Haploidentical Stem Cell Transplant for Treatment Refractory Hematological MalignanciesCompletedNCT00145613Phase 2
- HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's LymphomaCompletedNCT00144092Phase 2
- Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the BloodTerminatedNCT00143884Phase 2
- Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's LymphomaCompletedNCT00143871Phase 2
- Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's LymphomaTerminatedNCT00141700Phase 2
- Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabCompletedNCT00139841Phase 3
- Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00138164Phase 2
- Amifostine for Head and Neck Irradiation in LymphomaCompletedNCT00136474Phase 2
- Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)TerminatedNCT00133302Phase 3
- Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's LymphomaCompletedNCT00129090Phase 3
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 2
- Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma PatientsTerminatedNCT00120198Phase 2
- Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney FunctionCompletedNCT00118170Phase 1
- Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00117975Phase 2